Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer

Thyroid

Volumn 20, Issue 9, 2010, Pages 981-987

  Wolff, Erin F ^a   Hughes, Marybeth ^b   Merino, Maria J ^b   Reynolds, James C ^c   Davis, Jeremy L ^b   Cochran, Craig S ^c   Celi, Francesco S ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; FLUORODEOXYGLUCOSE F 18; LEVOTHYROXINE; LITHIUM; RADIOACTIVE IODINE; THYROGLOBULIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; ECHOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MULTIMODALITY CANCER THERAPY; OVARY CYST; OVARY TERATOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREGNANCY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THYROID CANCER; THYROIDECTOMY;

ABDOMINAL PAIN; ADULT; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPOTHYROIDISM; IODINE ISOTOPES; LITHIUM; MUTATION; OVARIAN CYSTS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS B-RAF; TERATOMA; THYROGLOBULIN; THYROID NEOPLASMS; THYROXINE; TREATMENT OUTCOME;

EID: 77956544844     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0458     Document Type: Article

References (38)

1. Dos Santos L, Mok E, Iasonos A, Park K, Soslow R, Aghajanian C, Alektiar K, Barakat R, Abu-Rustum N 2007 Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 105:321-324.
2. Devaney K, Snyder R, Norris H, Tavassoli F 1993 Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12: 333-343.
3. Savelli L, Testa A, Timmerman D, Paladini D, Ljungberg O, Valentin L 2008 Imaging of gynecological disease (4): clinical and ultrasound characteristics of struma ovarii. Ultrasound Obstet Gynecol 32:210-219.
4. Karseladze A, Kulinitch S 1994 Peritoneal strumosis. Pathol Res Pract 190:1082-1085; discussion 1086-1088.
5. Tennvall J, Ljungberg O, Högberg T 1997 Malignant struma ovarii with peritoneal dissemination. Histopathology 31: 289-290.
6. McGill J, Sturgeon C, Angelos P 2009 Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract 15:167-173.
7. Roth L, Talerman A 2007 The enigma of struma ovarii. Pathology 39:139-146.
8. Roth L, Karseladze A 2008 Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol 27:213-222.
9. Roth L, Miller AW 3rd, Talerman A 2008 Typical thyroidtype carcinoma arising in struma ovarii: a report of 4 cases and review of the literature. Int J Gynecol Pathol 27:496-506.
10. Ayhan A, Yanik F, Tuncer R, Tuncer Z, Ruacan S 1993 Struma ovarii. Int J Gynaecol Obstet 42:143-146.
11. Rim S, Kim S, Choi H 2005 Struma ovarii showing clinical characteristics of ovarian malignancy. Int J Gynecol Cancer 15:1156-1159.
12. Huh J, Montz F, Bristow R 2002 Struma ovarii associated with pseudo-Meigs syndrome and elevated serum CA 125. Gynecol Oncol 86:231-234.
13. Loizzi V, Cormio G, Resta L, Fattizzi N, Vicino M, Selvaggi L 2005 Pseudo-Meigs syndrome and elevated CA125 associated with struma ovarii. Gynecol Oncol 97:282-284.
14. Bokhari A, Rosenfeld G, Cracchiolo B, Heller D 2003 Cystic struma ovarii presenting with ascites and an elevated CA-125 level. A case report. J Reprod Med 48:52-56.
15. Amalaseelan J, Perera K 2008 An unusual variant of malignant struma ovarii. Ceylon Med J 53:55-56.
16. Zannoni G, Gallotta V, Legge F, Tarquini E, Scambia G, Ferrandina G 2004 Pseudo-Meigs syndrome associated with malignant struma ovarii: a case report. Gynecol Oncol 94:226-228.
17. Flavin R, Smyth P, Crotty P, Finn S, Cahill S, Denning K, Li J, ORegan E, OLeary J, Sheils O 2007 BRAF T1799A mutation occurring in a case of malignant struma ovarii. Int J Surg Pathol 15:116-120.
18. Schmidt J, Derr V, Heinrich M, Crum C, Fletcher J, Corless C, Nosé V 2007 BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol 31:1337-1343.
19. Coyne C, Nikiforov Y 2010 RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii. Endocr Pathol 21:144-147.
20. Celestino R, Magalhã es J, Castro P, Triller M, Vinagre J, Soares P, Sobrinho-Simõ es M 2009 A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology 55:482-487.
21. Tate G, Tajiri T, Suzuki T, Mitsuya T 2009 Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary. Cancer Genet Cytogenet 190:15-20.
22. Boutross-Tadross O, Saleh R, Asa S 2007 Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol 18:182-186.
23. McGill J, Sturgeon C, Angelos P 2009 Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract 15:167-173.
24. Trovisco V, Soares P, Soares R, Magalhã es J, Sá-Couto P, Sobrinho-Simõ es M 2005 A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 36:694-697.
25. Elisei R, Romei C, Castagna M, Lisi S, Vivaldi A, Faviana P, Marinò M, Ceccarelli C, Pacini F, Pinchera A 2005 RET/ PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid 15:1355-1361.
26. Sharma A, Sarda A, Chattopadhyay T, Kapur M 1996 The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behavior of well differentiated thyroid cancers. J Postgrad Med 42:39-42.
27. Matsuda K, Maehama T, Kanazawa K 2001 Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 82:575-577.
28. Berek J 2000 Preoperative prediction of optimal respectability in advanced ovarian cancer using CA-125. Gynecol Oncol 77:225-226.
29. Van Nostrand D, Atkins F, Moreau S, Aiken M, Kulkarni K, Wu J, Burman K, Wartofsky L 2009 Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma. Thyroid 19: 1093-1098.
30. Koong S, Reynolds J, Movius E, Keenan A, Ain K, Lakshmanan M, Robbins J 1999 Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 84:912-916.
31. Hinds SR 2nd, Stack A, Stocker D 2008 Low-iodine diet revisited: importance in nuclear medicine imaging and management. Clin Nucl Med 33:247-250.
32. Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J 1988 A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer. Clin Nucl Med 13:866-868.
33. Ceccarelli C, Bencivelli W, Morciano D, Pinchera A, Pacini F 2001 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab 86:3512-3515.
34. Raymond J, Izembart M, Marliac V, Dagousset F, Merceron R, Vulpillat M, Vallée G 1989 Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 69:186-190.
35. Seli E, Tangir J 2005 Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 17: 299-308.
36. Georgescu E, Goldberg J, du Plessis S, Agarwal A 2008 Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv 63:725-732.
37. Blumenfeld Z 2009 Preservation of fertility in patients with cancer. N Engl J Med 360:2680-2681; author reply 2682-2683.
38. Salvatori M, Dambra D, DAngelo G, Conte L, Locantore P, Zannoni G, Campo V, Campo S 2008 A case of metastatic struma ovarii treated with 131I therapy: focus on preservation of fertility and selected review of the literature. Gynecol Endocrinol 24:312-319.